title: [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
abstract: A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastasis and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies. Normal distant mucosa of the larynx reacted to anti class I antibodies. In 13 primary tumours HLA class I antigens were not found. The remaining 47 showed a strong reaction to anti HLA-ABC (heavy chain) and anti beta 2-microglobulin, although in 5 cases staining was not observed with anti HLA-A locus specific monoclonal antibodies. Other tumour showed a selective loss of HLA-B antigens. These selective losses were confirmed using the correspondent anti-HLA polymorphic monoclonal antibodies. We have found differences in HLA class I expression when comparing primary tumours and autologous metastasis (3/15 cases). Finally, to further analyse the mechanism responsible for the HLA phenotypic changes observed, immunoprecipitation and SDS-PAGE of class I antigens, Northern and Southern blot analysis of MHC class I genes were performed. We have not detected class I gene rearrangement using HLA coding and locus specific non coding probes. However we have found a class I transcription defect in a class I negative tumour.
authors.affiliation: Servicio de ORL, Ciudad Sanitaria Virgen de las Nieves, Granada.
authors.forename: F
authors.initials: F
authors.lastname: Esteban
authors.forename: A
authors.initials: A
authors.lastname: Concha
authors.forename: F
authors.initials: F
authors.lastname: Ruiz-Cabello
authors.forename: F
authors.initials: F
authors.lastname: Garrido
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis* / Q000235:genetics; D006801:Humans; D007822:Laryngeal Neoplasms / Q000276:immunology*
chemical_list: D006680:HLA Antigens
vernacular_title: Modulación inmunológica de la agresividad tumoral en el cáncer de laringe. I. Estudios genético y molecular de los antígenos HLA de clase I.